December 13, 2016 - The court approved the settlement and entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissing the action with prejudice.
July 7, 2016 - An order providing for notice was filed by the court.

July 1, 2016 - Parties filed a second revised stipulation of settlement.

June 6, 2016 - Parties filed a revised stipulation of settlement.

May 6, 2016 - Parties filed a stipulation of settlement.

July 1, 2015 - The court denied defendants' motion to dismiss.

December 15, 2014 - Defendants filed a motion to dismiss.

October 14, 2014 - The lead plaintiff filed a consolidated complaint.

August 15, 2014 - The lead plaintiff and lead counsel were appointed and all cases were consolidated.

May 30, 2014 - An investor in shares of Covisint Corporation (NASDAQ: COVS) filed a lawsuit in the U.S. District Court for the Southern District of New York over against Covisint Corporation over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made in connection with Covisint Corporation’s September 26, 2013 initial public stock offering.

According to the complaint the plaintiff alleges on behalf of purchasers of Covisint Corp (NASDAQ: COVS) common shares pursuant and/or traceable to Covisint Corporation’s September 26, 2013 initial public stock offering (“IPO”), that Covisint Corporation, certain of its officers and directors and the underwriters of the IPO violated that Securities Act of 1933.

The plaintiff claims that the registration statement, and the documents referenced and incorporated therein, allegedly negligently failed to disclose that Covisint Corporation was experiencing a greater than expected decline in its subscription revenue due to poor sales execution and late-stage pipeline conversion issues, that Covisint Corporation was facing increased competition in its services segment as customers were not adding services at a rate consistent with expectations, that Covisint Corporation was experiencing a decline in General Motors-related service revenue, that Covisint Corporation was losing healthcare customers at an increasing rate and its pipeline of healthcare-related deals was steadily declining and included numerous deals that were not likely to be consummated, and that as a result of the foregoing, there was no reasonable basis to “expect” revenues for 2014 to increase by 20% from 2013.

The plaintiffs says that these known, but undisclosed, facts had a material adverse effect on Covisint Corporation’s operating results during its fourth quarter and fiscal 2014 full-year.

Covisint Corporation reported that its Total Revenue rose from $40.45 million for the 12 months period that ended on March 31, 2010 to $90.73 million for the 12 months period that ended on March 31, 2013.

On September 26, 2013 Covisint Corporation (NASDAQ: COVS) stock opened for trading at $12.60 the day the Company sold 6.4 million shares of stock in its initial public stock offering (the IPO ).

Shares of Covisint Corporation (NASDAQ: COVS) reached $14.46 per share in late October 2013.

Then on January 23, 2014, Covisint Corporation announced its third quarter fiscal 2014 earnings results. Shares of Covisint Corporation declined from $12.84 per share on January 23, 2014 to $8.74 per share on January 27, 2014.

Then on March 13, 2014, Covisint Corporation announced its preliminary Q4 fiscal year 2014 result and named Sam Inman interim CEO. Shares of Covisint Corporation declined from $11.41 per share on March 7, 2014, to as low as $5.04 per share on May 30, 2014.